Welcome to the AIC’s financial adviser centre. Here, you can access statistics, performance data, training, news, guides and videos on the investment company industry, including investment trusts and VCTs. All our services for financial advisers and wealth managers are free of charge and our CPD is accredited by professional bodies.
Ian Cowie examines a relatively good year for biotech and healthcare investment companies.
Polar Capital Healthcare explain why big pharma shouldn’t be ignored.
David Prosser asks the all-important question. Which investment companies will outperform in 2019?
In this month’s issue we look at healthcare and millennials, where Polar Capital Global Healthcare explain why big pharma shouldn't be ignored. Ian Cowie examines a relatively good year for biotech and healthcare investment companies. Investment Week columnist Jayna Rana examines the advantages of investing in investment companies for younger generations.
BB Healthcare manager, Paul Major, on why healthcare could be one investment area untainted by Brexit.
David Prosser explains how investment companies could be the answer for investors wanting exposure to alternative asset classes.
David Prosser highlights continued efforts by the sector to cut and restructure fees.
Simon Edelsten – Mid Wynd International, Jean Roche – Schroder UK Mid Cap and Peter Spiller – Capital Gearing, explain why ignoring political noise and trade wars being resolved will be key to their success in 2019.
Peter Spiller – Capital Gearing, explains why he is looking to inflation-linked investments to protect his portfolio from threats.
Jean Roche – Schroder UK Mid Cap, discusses how online disruption and overseas earnings are helping to protect her UK portfolio from Brexit uncertainty.
After a tough 2018, David Prosser looks at how investors can position themselves for 2019 and the part investment companies could play in managing volatility.
Simon Edelsten – Mid Wynd International, explains why automation presents both an opportunity and a threat.